STEWARTVILLE, Minn., Jan. 23 /PRNewswire-FirstCall/ -- Rochester
Medical Corporation (NASDAQ:ROCM) today announced operating results
for its first quarter ending December 31, 2006. The Company
reported record sales of $7,512,000 for the current quarter
compared to $4,607,000 for the first quarter of last year. It also
reported net income of $31,467,000 or $2.59 per diluted share
compared to a net income of $311,000 or $.03 per diluted share for
the first quarter of last year. To aid in further comparison
between the quarters, the Company notes that: -- The current
quarter results include $38,605,000 of income resulting from the
previously announced lawsuit settlements. -- The current quarter
results include $7,344,000 of income tax expense. -- The results
for the current quarter include $1,267,000 of non-cash expenses
comprised of $1,104,000 related to non-cash stock option expenses
under FAS123R and $163,000 for amortization of intangibles related
to the 2006 asset acquisitions. Last year's first quarter results
included $84,000 of non-cash expenses which were stock option
expenses under FAS123R. Income from operations for the first
quarter of 2007 adjusted on a non- GAAP basis to exclude these
non-cash expenses was $1,557,000 compared to $341,000 for the first
quarter of last year with the same adjustments. The 63% increase in
sales revenues for the current quarter compared to last year's
first quarter resulted from increased Rochester Medical(R) Brand
sales, primarily attributable to increased international sales of
Rochester Medical Brand products resulting from the previously
announced acquisition in the United Kingdom, and also from
increased Private Label sales. The Company noted that it utilized
its entire Net Operating Loss carryforward this quarter which
explains the low tax expense relative to the income. "This has
certainly been an eventful quarter," said Company CEO and President
Anthony J. Conway. "We were awarded a National Group Purchasing
Contract by Premier Purchasing Partners, L.P.; we renewed our
Private Label sales agreement with Hollister, Inc.; we secured two
lawsuit settlements in our anti-trust litigation; and we realized
strong sales and earnings. We are pleased with the Company's
progress, and we look forward to a good year." The Company will
hold a quarterly conference call this afternoon to discuss its
earnings report. The call will begin at 4:00 p.m. central time
(5:00 p.m. eastern time). This call is being webcast by
Thomson/CCBN and can be accessed at Rochester Medical's website at
http://www.rocm.com/ . To listen live to the conference call via
telephone, call: Domestic: 1-800-561-2813, password 41026628
International: 617-614-3529, password 41026628 Replay will be
available for seven days at: http://www.rocm.com/ or via telephone:
Domestic Replay: 1-888-286-8010, password 92111833 International
Replay: 617-801-6888, password 92111833 The webcast is also being
distributed through the Thomson StreetEvents Network to both
institutional and individual investors. Individual investors can
listen to the call at http://www.fulldisclosure.com/ ,
Thomson/CCBN's individual investor portal, powered by StreetEvents.
Institutional investors can access the call via Thomson's
password-protected event management site, StreetEvents (
http://www.streetevents.com/ ). This press release contains
forward-looking statements that involve risks and uncertainties,
including the uncertainty of estimated revenues and profits, as
well as the uncertainty of market acceptance of new product
introductions, the uncertainty of gaining new strategic
relationships, the uncertainty of timing of private label sales
revenues (particularly international customers), FDA and other
regulatory review and response times, the uncertainty of
successfully integrating and growing the Company's new UK
operations, and other risk factors listed from time to time in the
Company's SEC reports and filings, including, without limitation,
the section entitled "Risk Factors" in the Company's Annual Report
on Form 10-K for the year ended September 30, 2006. Rochester
Medical Corporation develops, manufactures, and markets disposable
medical catheters and devices for urological and continence care
applications. The Company markets under its own Rochester
Medical(R) brand and under existing private label arrangements. For
further information, please contact Anthony J. Conway, President
and Chief Executive Officer of Rochester Medical Corporation at
(507) 533-9600. More information about Rochester Medical is
available on its website at http://www.rocm.com/ . Condensed
Balance Sheets (unaudited) December 31, September 30, 2006 2006
Assets Current Assets Cash and equivalents $42,220,924 $2,906,698
Marketable securities - - Accounts receivable 4,378,917 4,494,094
Inventories 5,466,581 4,642,578 Prepaid expenses and other assets
517,975 410,267 Deferred income tax asset 542,000 53,000 Total
current assets 53,126,397 12,506,637 Property and equipment
8,386,469 8,239,246 Deferred income tax asset 440,000 1,177,999
Patents, net 280,933 271,172 Intangible assets, net 8,106,776
8,270,157 Goodwill 5,422,490 5,487,141 Total Assets $75,763,065
$35,952,352 Liabilities and Stockholders' Equity Current
liabilities: Accounts payable $1,444,379 $1,278,441 Accrued
expenses 1,467,686 1,621,376 Short term debt 1,681,361 1,681,361
Current maturities of capital leases 42,679 42,084 Income taxes
payable 6,777,350 105,559 Deferred revenue 100,000 114,287 Total
current liabilities 11,513,455 4,843,108 Long-term liabilities Long
term debt 7,327,214 7,540,737 Capital leases, less current portion
11,050 21,946 Deferred revenue 425,000 449,999 Total long term
liabilities 7,763,264 8,012,682 Stockholders' equity 56,486,346
23,096,562 Total Liabilities and Stockholder Equity $75,763,065
$35,952,352 Summary Statements Of Operations (unaudited) Three
months ended December 31, 2006 2005 Sales $7,511,966 $4,607,200
Cost of sales 3,736,344 3,005,470 Gross profit 3,775,622 1,601,730
Gross profit % 50% 35% Costs and expense: Marketing and selling
1,233,662 598,993 Research and development 202,770 173,623 General
and administrative 2,049,146 572,255 Total operating expenses
3,485,578 1,344,871 Income from operations 290,044 256,859 Other
income (expense) Interest income 74,850 57,125 Interest expense
(159,647) (2,606) Other income 38,605,000 - Net income before
income taxes 38,810,247 311,378 Income tax expense 7,343,640 - Net
income $31,466,607 $311,378 Earnings per common share - Basic $2.83
$0.03 Earnings per common share - Diluted $2.59 $0.03 Weighted
Average Shares: Basic 11,102,034 11,052,376 Weighted Average
Shares: Diluted 12,158,281 11,504,740 DATASOURCE: Rochester Medical
Corporation CONTACT: Anthony J. Conway, President and Chief
Executive Officer of Rochester Medical Corporation, +1-507-533-9600
Web site: http://www.rocm.com/
Copyright
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2024 to Jun 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jun 2023 to Jun 2024